THE LATE PHASE OF ISCHEMIC PRECONDITIONING (PC) is a powerful adaptive phenomenon evoked by brief episodes of ischemia that renders the heart resistant to subsequent ischemic stress occurring 24-72 h later (2, 4, 15) . Recent evidence supports a role of protein tyrosine kinases (PTKs) in the signaling mechanism underlying the late phase of PC (8, 9, 13, 23) . Specifically, administration of genistein (1), a rather nonspecific inhibitor of various kinases, prior to the PC ischemia, has been reported to block the development of late PC against infarction in open-chest rabbits (13) . In conscious rabbits, inhibition of the Src family of PTKs with lavendustin A (LD-A) has been found to abrogate late PC against myocardial stunning (9) . The late PC protection was abolished both when LD-A was administered on day 1 (prior to the PC ischemia) and when it was given on day 2 (prior to the index ischemia), suggesting a role of Src PTK signaling both in the initiation and in the mediation of protection (9) . Consistent with this, two members of the Src family of PTKs, Src and Lck, have been shown to be activated shortly after the PC stimulus (on day 1) (14, 31) as well as 24 h later (on day 2) (41) . In addition, pretreatment with genistein has been shown to decrease heat shock protein 72 expression 24 h after PC ischemia, to suppress action potential duration shortening during the index ischemia, and to abrogate late PC protection against infarction in open-chest rabbits (23) . A role of PTKs in adenosine A 1 receptor agonist-induced delayed protection against infarction has also been reported (8) . Recent studies in Lck Ϫ/Ϫ mice have provided unequivocal evidence for an obligatory role of this PTK in late PC against infarction (29) .
Although these studies (8, 9, 13, 14, 23, 31, 41) implicate PTKs in the signaling pathways of late PC, the role of these kinases in late PC against myocardial infarction remains unclear. In this regard, it is important to distinguish the cellular mechanisms that initiate (trigger) the development of late PC immediately after the first ischemic stress (day 1) from those that mediate cardioprotection 24-72 h later (days 2-4). While several previous studies (8, 13, 23) examined the role of PTKs in triggering late PC against infarction on day 1, the role of PTKs as mediators of cardioprotection on day 2 has not been explored. Thus it is unknown whether PTK-dependent signaling is important only to trigger or also to mediate late PC against lethal ischemia-reperfusion injury. The bifunctional role (triggers and mediators) of PTKs observed in the setting of late PC against myocardial stunning (9) cannot be extrapolated to late PC against myocardial infarction because stunning and infarction represent two different types of cellular injury. Furthermore, ischemic PC activates not only Src and Lck (31), but also protein kinase C (PKC) (30) , and possibly various other kinases. Most previous studies examining the role of PTKs in late PC against infarction have used genistein (13, 23) . Despite its initial description as a specific inhibitor of PTKs (1), genistein is now known to exhibit extensive nonspecific actions, including inhibition of serine-threonine kinases [e.g., PKC and protein kinase A (PKA)] (1, 11), action on multiple ion channels (22, 27) , inhibition of topoisomerase II (17) , and inhibition of reactive oxygen species (ROS) production in response to specific stimuli (37) . Because of these potential confounding actions of genistein, it remains unclear whether the effects observed with genistein in the previously reported studies (13, 23) can be ascribed specifically to inhibition of PTK activity.
The present study was undertaken to address these unresolved issues. Using a conscious rabbit model, we tested the hypothesis that PTKs play a dual role (triggers and mediators) in the pathophysiology of late PC against myocardial infarction, i.e., that they are essential not only for the initiation of this phenomenon on day 1 but also for the manifestation of cardioprotection on day 2. Accordingly, this study had two aims. First, we determined whether administration of the PTK inhibitor LD-A prior to the first ischemic stress (on day 1) blocks the development of late PC against myocardial infarction. Second, we investigated whether administration of LD-A prior to the second ischemic stress (on day 2) abrogates the cardioprotection afforded by late PC against infarction. None of the currently available PTK inhibitors is absolutely specific. Although LD-A has been reported to inhibit phosphatidylinositol-3 kinase (25), GLUT-1 (40) , and the muscarinic K ϩ current (26) , this agent was chosen because 1) it has fewer nonspecific actions than genistein (21, 24, 25) , 2) it is more selective for the Src family of PTKs than other PTK inhibitors (21, 24) , and 3) it has previously been shown to inhibit Src and Lck PTKs in our conscious rabbit model of late PC (31) .
METHODS
The present study was performed in accordance with the guidelines of the Animal Care and Use Committee of the University of Louisville School of Medicine and with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (Department of Health and Human Services, Publication No. 86-23).
Experimental preparation. The conscious rabbit model of myocardial infarction has been described in detail previously (35) and will be briefly summarized here. New Zealand White male rabbits (weight, 2.0-3.0 kg) were instrumented under sterile conditions with a balloon occluder around a major branch of the left coronary artery, a 10-MHz pulsed Doppler ultrasonic crystal in the center of the region to be rendered ischemic, and bipolar electrocardiogram (ECG) leads on the chest wall. The wires and the occluder tubing were tunneled under the skin and exteriorized through small incisions between the scapulae. The chest wound was closed in layers, and a small tube was left in the thorax for 3 days to evacuate air and fluids postoperatively. Gentamicin was administered before surgery and on the first and second postoperative days (0.5 mg/kg im each day). Rabbits were allowed to recover for a minimum of 10 days after surgery.
Experimental protocol. Throughout the experiments, rabbits were kept in a cage in a quiet, dimly lit room. Left ventricular (LV) systolic wall thickening (WTh), range gate depth, and the ECG were recorded throughout the experiments on a thermal array chart recorder (Gould TA6000; Valley View, OH). Regional myocardial function was assessed as systolic thickening fraction by use of the pulsed Doppler probe, as previously described (7) . All rabbits were subjected to a 30-min coronary artery occlusion followed by 3 days of reperfusion. The performance of successful coronary occlusion was verified by observing the development of S-T segment elevation and changes in the QRS complex on the ECG and the appearance of paradoxical wall thinning on the ultrasonic crystal recordings. Diazepam was administered 20 min before the onset of ischemia (4 mg/kg ip) to relieve the stress caused by the coronary occlusion. No antiarrhythmic agents were given at any time.
The experimental protocol is illustrated in Fig. 1 . Rabbits were assigned to four groups (Fig. 1) . Group I (control group) underwent a 30-min occlusion with no PC protocol and no drug treatment. Group II (PC group) underwent a sequence of six 4-min coronary occlusions interspersed with 4-min intervals of reperfusion 24 h before the 30-min coronary occlusion. Group III (PC ϩ LD-A on day 1 group) underwent the same protocol as group II except that the rabbits received an intravenous bolus of LD-A (1 mg/kg) 10 min before the six occlusion/reperfusion cycles of PC ischemia. Group IV (LD-A on day 2 group) underwent the same protocol as group III except that the rabbits received LD-A on day 2, 10 min prior to the 30-min occlusion. LD-A (Calbiochem; San Diego, CA) was dissolved under sterile conditions in 10% (vol/vol) dimethylsulfoxide (DMSO) in normal saline (total dose of DMSO, 0.1 ml/kg; total volume infused, 1 ml/kg). This dose of LD-A has been shown to completely block the activation of Src and Lck PTKs after the six 4-min occlusion/reperfusion cycles in our conscious rabbit model (31) .
Measurement of regional myocardial function. Regional myocardial function was assessed as systolic thickening fraction by use of the pulsed Doppler probe, as previously described (7). Percent systolic thickening fraction was calculated as the ratio of net systolic WTh to end-diastolic WTh, multiplied by 100 (7). The total deficit of systolic WTh over the 3-day reperfusion period (an integrative assessment of the overall severity of contractile dysfunction during this time interval) was calculated by measuring the area between the systolic WTh versus time line and the baseline (100% line) during the 3-day recovery phase after the 30-min coronary occlusion (5) . In all animals, measurements were averaged from 10 beats at baseline and from 5 beats at all subsequent time points.
Measurement of region at risk and infarct size. At the conclusion of the study, the rabbits were given heparin (1,000 units iv), after which they were anesthetized with pentobarbital sodium (50 mg/kg iv) and euthanized with KCl. The heart was excised, and the size of the ischemic-reperfused region (region at risk) was determined by tying the coronary artery at the site of the previous occlusion and by perfusing the aortic root for 2 min with a 5% solution of Phthalo blue dye in normal saline at a pressure of 70 mmHg using a Langendorff apparatus. The heart was then cut into six to seven transverse slices, which were incubated for 10 min at 37°C in a 1% solution of triphenyltetrazolium chloride in phosphate buffer (pH 7.4). All atrial and right ventricular tissues were excised. The slices were weighed, fixed in a 10% neutral buffered formaldehyde solution, and photographed (Nikon AF N6006). Transparencies were projected onto a paper screen at a 10-fold magnification, and the borders of the infarcted, ischemic-reperfused, and nonischemic regions were traced. The corresponding areas were measured by computerized planimetry (Adobe Photoshop, version 4.0), and from these measurements, infarct size was calculated as a percentage of the region at risk (35) .
Statistical analysis. Data are reported as means Ϯ SE. Heart rate and thickening fraction were analyzed by a twoway repeated-measures ANOVA (time and group). Infarct sizes and risk region sizes were analyzed with a one-way ANOVA followed by Student's t-tests for unpaired data with the Bonferroni correction (32, 42) . The relationship between infarct size and risk region size was compared among groups with an analysis of covariance (ANCOVA), with size of the risk region used as the covariate. The correlation between infarct size and risk region size was assessed by linear regression analysis using the least-squares method. All statistical analyses were performed using the SAS software system (32).
RESULTS

Exclusions.
Of the 40 rabbits instrumented for this study, 11 were assigned to the control group (group I), 11 to the PC group (group II), 9 to the PC ϩ LD-A on day 1 group (group III), and 9 to the PC ϩ LD-A on day 2 group (group IV). Five rabbits died of ventricular fibrillation during coronary occlusion (1 in the control group, 1 in the PC group, 2 in the PC ϩ LD-A on day 1 group, and 1 in the PC ϩ LD-A on day 2 group). Therefore, a total of 10 rabbits completed the protocol in the control group, 10 in the PC group, 7 in the PC ϩ LD-A on day 1 group, and 8 in the PC ϩ LD-A on day 2 group. No rabbit included in the final analysis was subjected to defibrillation.
Hemodynamic variables. Previous studies in conscious rabbits have shown that the dose of LD-A used in the present investigation does not affect systemic arterial pressure, heart rate, or systolic thickening fraction (9) . On the day of the 30-min coronary occlusion, heart rate did not differ among the four groups at baseline (pretreatment), after treatment (preocclusion), at 15 min into the occlusion, and at 1, 3, and 5 h of reperfusion (Table 1) .
Region at risk and infarct size. There were no significant differences among groups I, II, III, and IV with (Fig. 2) ], indicating a late PC effect against myocardial infarction. In group III, infarct size (24.6 Ϯ 6.6% of the region at risk) was also smaller than in controls and essentially indistinguishable from the PC group (Fig. 2) , indicating that LD-A, when administered prior to the PC ischemia on day 1, did not have any appreciable effect on the development of late PC against infarction. In group IV, however, infarct size (54.4 Ϯ 3.8% of the region at risk) was similar to that in the control group and significantly larger than that in group II, indicating that administration of LD-A on day 2 completely abrogated the protective effects of late PC against infarction. In all four groups, the size of the infarction was positively and linearly related to the size of the region at risk (r ϭ 0.80, 0.57, 0.84, and 0.81 in groups I, II, III, and IV, respectively). As expected, the regression line was significantly shifted to the right in group II compared with group I (P Ͻ 0.05 by ANCOVA) (Fig. 3) and group IV, indicating that late PC reduced infarct size independent of the risk region size and that this protective effect was abrogated by administration of LD-A on day 2. In contrast, in group III, regression line was very similar to that in group II and significantly different (P Ͻ 0.05 by ANCOVA) from that in group I, indicating that for any given size of the region at risk, the resulting infarction was smaller in preconditioned rabbits treated with LD-A prior to the PC ischemia on day 1 than in untreated control rabbits (Fig. 3) . Regression equations are given in the legend to Fig. 3 . and IV, respectively (P ϭ not significant). After release of the 30-min occlusion, control rabbits (group I) exhibited essentially no recovery of WTh even at 3 days (Fig.  4) . In preconditioned rabbits (group II), recovery of WTh was significantly (P Ͻ 0.05) improved compared with controls at 5 h, 1 day, 2 days, and 3 days after reperfusion (Fig. 4) . The total deficit of WTh over the 3-day reperfusion period [an integrative assessment of the overall severity of contractile dysfunction during this time interval (5)] was decreased by 22% in group II versus group I (P Ͻ 0.05) (Fig. 4) . In group III (LD-A on day 1 group), the total deficit of WTh was 13% less than that in group I (P Ͻ 0.05), indicating that administration of LD-A on day 1 did not abolish the late PC protection. Administration of LD-A on day 2, however, abrogated the salutary actions of late PC on recovery of myocardial function in group IV and the total deficit of WTh was similar to that in the control group (group I).
DISCUSSION
Despite identification of several key components, including nitric oxide (NO), ROS, PKC, nuclear factor-B, signal transducer and activator of transcription (STAT)1/3, and prostanoids (4), the molecular mechanisms that underlie the development and mediation of late PC remain incompletely understood. Recent studies have shown that ischemic PC activates two members of the Src family of PTKs, Src and Lck, in the rabbit heart (31) , that PTKs are involved in both the initiation and in the mediation of the delayed protec- Data (in beats/min) are means Ϯ SE. In group I, rabbits underwent a 30-min coronary occlusion on day 2 followed by a 72-h observation period. Heart rate was measured at baseline (before treatment), 1 min before occlusion (preocclusion), at 15 min into the 30-min coronary occlusion, and at selected times after reperfusion. In groups II, III, and IV, rabbits underwent a sequence of 6 cycles of 4-min coronary occlusion/4-min reperfusion followed by a 5-h observation period on day 1. Heart rate was measured 1 min before occlusion (preocclusion), at 3 min into the 6th occlusion, and at selected times after the 6th reperfusion. On day 2, rabbits underwent a 30-min coronary occlusion followed by a 72-h observation period; heart rate was measured at baseline (before treatment), 1 min before occlusion (preocclusion), at 15 min into the 30-min coronary occlusion, and at selected times after reperfusion. PC, preconditioning; LD-A, lavendustin A. Fig. 2 . Myocardial infarct size in groups I (control group), II (PC group), III (PC ϩ LD-A on day 1 group), and IV (PC ϩ LD-A on day 2 group). Infarct size is expressed as a percentage of the region at risk of infarction. E, Individual rabbits; F, means Ϯ SE; n, number of rabbits. tion against myocardial stunning via upregulation of NO synthesis in rabbits (9) , and that Lck is necessary for the initiation and/or mediation of late PC against infarction in mice (29). The role of PTKs in the initiation versus mediation of late PC against infarction, however, is unclear. Furthermore, nonuniform results have been reported concerning the function of PTKs in early PC against myocardial infarction (10, 14, 18, 19, 38) .
Salient findings. Utilizing a conscious rabbit model, we found that administration of LD-A prior to the PC ischemia (on day 1), at a dose that blocks Src/Lck activation (31), failed to block the protective effects of late PC against myocardial infarction, indicating that Src PTK activity is not necessary for the development of this phenomenon. In contrast, the infarct-sparing effects of late PC were completely abrogated when LD-A was administered on day 2, indicating a pivotal role of Src PTKs in the mediation of protection. To our knowledge, this is the first study to demonstrate that PTKs are involved in the mediation (on day 2) as opposed to the initiation (on day 1) of delayed protection against myocardial infarction, a finding which reveals a new role of PTKs in late PC.
PTK activity and development of late PC against infarction (day 1). Our data indicate that, although Src PTK activity is increased soon after the PC stimulus (31), it is not essential for the development (as trigger) of delayed protection against infarction. In contrast, Src PTK activity is necessary for the development of late PC against myocardial stunning in conscious rabbits (9) . Specifically, the initiation of this phenomenon was abrogated by administration of LD-A (at the same dose as that used in the present investigation) prior to the PC ischemia. This dose of LD-A also abolished the late PC-induced increase in inducible NO synthase (iNOS) activity 24 h later, indicating a role of Src PTK signaling in transcriptional modulation of iNOS (9) . The present finding that LD-A, administered on day 1, failed to block the infarct-sparing effects of late PC indicates that the signaling mechanism responsible for the delayed protection against infarction can be initiated without involvement of Src PTKs. The difference between these results and those obtained previously in the setting of late PC against stunning (9) can be Fig. 3 . Relationship between size of the region at risk and size of myocardial infarction. Illustrated are both individual values and regression lines obtained by linear regression analysis for groups I (control group), II (PC group), III (PC ϩ LD-A on day 1 group), and IV (PC ϩ LD-A on day 2 group). In all groups, infarct size was positively and linearly related to the risk region size. Linear regression equations were as follows: group I, y ϭ 0.44x ϩ 0.07 (r ϭ 0.80); group II, y ϭ 0.22x ϩ 0.67 (r ϭ 0.57); group III, y ϭ 0.58x Ϫ 0.22 (r ϭ 0.84); and group IV, y ϭ 0.50x ϩ 0.04 (r ϭ 0.81). Analysis of covariance demonstrated that the slope of the regression line for group II was significantly different (P Ͻ 0.05 for each comparison) from those for groups I and IV, indicating that for any given risk region size, infarct size was smaller in group II compared with groups I and IV. These data demonstrate that late PC reduced infarct size independent of risk region size and that this effect was abrogated by administration of LD-A on day 2, but not by LD-A was given on day 1, or when given on day 2 without prior PC ischemia. rationalized when one considers that myocardial stunning and infarction represent two very different types of injury, and that at least under certain experimental conditions, different signaling components may be involved in the PC protection against reversible and irreversible ischemic injury (3). It must be stressed that the dose of L-DA used in the present study has been shown to completely block the activation of Src PTKs associated with ischemic PC in this same conscious rabbit model (31) . Therefore, the inability of L-DA to block late PC in the present study cannot be ascribed to lack of effectiveness of the inhibitor.
The fact that inhibition of Src PTKs by LD-A blocks protection against infarction but not protection against stunning is congruent with the emerging notion that late PC is a polygenic phenomenon with multiple, often overlapping and/or redundant signaling and effector pathways (4) . Besides PKC-⑀ and Src PTKs, recent evidence indicates that other stress-responsive pathways (e.g., the Janus kinase-STAT cascade) (43) are involved in this phenotypic shift. It is conceivable that the precise pathways recruited during the development of late PC may vary depending upon the stimulus (e.g., ischemia versus pharmacological or physical stimuli) and the end point (infarction versus stunning) (4). Important mechanistic differences among different forms of late PC have already been demonstrated, such as the fact that ATP-sensitive K ϩ (K ATP ) channels play an essential role in late PC against infarction but not in late PC against stunning (36) , that increased NOS activity is essential for adenosine A 1 receptor-induced but not adenosine A 3 receptor-induced late PC (34) , and that activation of adenosine A 1 receptors induces late PC against infarction (34) but not against stunning (16).
We have recently found that genetic ablation of Lck abrogates the infarct-sparing effects of ischemia-induced late PC in mice (29) . Apart from the obvious species difference, this result is not in contrast with our present data in rabbits, since it is plausible that Lck plays an obligatory role in the mediation (as opposed to the initiation) of late PC in both mice and rabbits. Targeted deletion of Lck does not enable one to discern whether Lck is acting as a trigger of late PC (on day 1) or as a mediator (on day 2). We propose that the loss of protection in Lck Ϫ/Ϫ mice (29) indicates that Lck activity is indispensable to mediate cardioprotection 24 h after the ischemic PC stimulus, not to trigger the development of the PC phenotype immediately after the ischemic PC stimulus, which would be consistent with our findings in rabbits.
Our observations seem to be at variance with those of three previous studies (8, 13, 23) that have suggested a role of PTKs in the initiation of late PC against infarction. Two of these studies (13, 23) used genistein to achieve broad-spectrum PTK inhibition, whereas another study (8) interrogated the mechanism of adenosine A 1 receptor-induced late PC. The apparent discrepancy between these studies and our current observations could be the result of several factors. First, genistein has numerous nonspecific actions, including inhibition of PKC and PKA (1), inhibition of topoisomerase II (17) , inhibition of ROS generation (37) , and effects on several ion channels in various tissues and cell lines (22, 27) . Thus genistein may potentially interact with several other key elements of late PC signaling, including ROS (37), PKC (1, 11) , and the K ATP channel (22) . In the present study, the use of LD-A, an inhibitor of PTKs with fewer nonspecific (i.e., PTK unrelated) actions (21, 24) , minimized interactions with other cellular kinases. Second, at least in early PC signaling, contradictory findings regarding the role of PTKs have been observed when experiments were carried out in different animal species and under different experimental conditions (10, 14, 18) . The use of conscious animals (as in the present study) eliminates the confounding effects of factors associated with open-chest preparations, such as anesthesia, surgical trauma, fluctuations in temperature, elevated catecholamines, excessive free radical formation, and release of cytokines. These factors may potentially interfere with PTK activity, PC signaling, myocardial infarct size, or a combination of these (12, 33) . Third, at least several hundred PTKs are known to exist (20) , and it is possible that non-Src PTKs may also be involved in late PC. In the present study the use of LD-A, a selective inhibitor of the Src and epidermal growth factor (EGF) receptor subfamilies of PTKs (21, 24) , enabled us to interrogate these enzymes but did not provide information regarding the potential involvement of other PTKs. Thus the possibility that adenosine A 1 receptor-induced late PC (8) may signal through subset(s) of PTKs different from those recruited by ischemia and with different susceptibility to inhibitors cannot be ruled out. Finally, the sheer number of PTKs (20, 39) , their widely different susceptibilities to various classes of inhibitors, and the plethora of known and unknown signaling functions of this superfamily of enzymes make it difficult, if not impossible, to generalize any finding derived from the use of a single agent with a rather narrow spectrum of inhibition. As mentioned above, LD-A targets the Src and EGF receptor subfamilies of PTKs (21, 24) but fails to inhibit many other PTKs whose roles in the setting of late PC signal transduction have not yet been tested. On the basis of the observations reported herein, the involvement of LD-A-insensitive but genistein-sensitive PTKs in the proximal signaling events of late PC against infarction cannot be excluded.
PTK activity and mediation of protection (day 2).
A novel finding of the present study was that LD-A abolished the delayed infarct-sparing effects of late PC when administered on day 2, prior to the 30-min coronary occlusion. To our knowledge, this is the first evidence that PTK activity is essential for the mediation (as opposed to the initiation) of late PC protection against infarction. Although our findings were obtained in the setting of ischemic PC, they may help to elucidate the functional significance of the increase in Src kinase activity observed 24 h after diethylenetriamine/nitric oxide-induced PC (41) . The mechanism whereby PTKs participate in the mediation of late PC H554 TYROSINE KINASES AND LATE PRECONDITIONING remains to be ascertained. Since iNOS plays an obligatory role in the manifestation of delayed protection against both myocardial stunning and infarction (6, 35) and since administration of L-DA on day 2, prior to the second ischemic challenge, inhibits the increased iNOS activity associated with late PC (9), a plausible explanation for our findings is that PTK activity on day 2 leads to cardioprotection by augmenting iNOS activity via posttranslational modulation of iNOS by tyrosine phosphorylation. This concept is consistent with the fact that tyrosine phosphorylation of iNOS is associated with increased iNOS activity in murine macrophages (28) . However, one cannot exclude the possibility that tyrosine phosphorylation and consequent activation of other mediators of late PC (e.g., cyclooxygenase-2) may also contribute. Further studies will be necessary to identify the exact signaling events governed by PTKs on day 2.
In conclusion, this study expands our understanding of the signaling infrastructure responsible for late PC against infarction by demonstrating that, in conscious rabbits, Src PTK activity is essential for this cardioprotective phenotype to become manifest 24 h after the PC stimulus (on day 2). Somewhat surprisingly, Src PTK activity does not appear to be required for the initiation of this delayed cardioprotective adaptation on day 1, a finding that contrasts with the previous demonstration that Src PTK activity is necessary for the initiation of ischemia-induced late PC against myocardial stunning (9) . The present data imply that the mechanisms responsible for late PC against stunning and infarction are different, which adds to previous evidence pointing in this direction (4, 16, 36) .
